Ricardo Jorge Dinis-Oliveira

Prof. Ricardo Jorge Dinis-Oliveira

TOXRUN - Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, Portugal
+2
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Critical Reviews in Toxicology
Verified
Journal Article
Closed access
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
JDJosé Alberto Duarte
José Alberto Duarte
Amparo Sánchez NavarroAmparo Sánchez Navarro
Amparo Sánchez Navarro
Fernando RemiãoFernando Remião
Fernando Remião
MBM. L. Bastos
M. L. Bastos
Félix CarvalhoFélix Carvalho
Félix Carvalho
Paraquat dichloride (methyl viologen; PQ) is an effective and widely used herbicide that has a proven safety record when appropriately applied to eliminate weeds. However, over the last decades, there have been numerous fatalities, mainly caused by accidental or voluntary ingestion. PQ poisoning is an extremely frustrating condition to manage clinically, due to the elevated morbidity and mortality observed so far and due to the lack of effective treatments to be used in humans. PQ mainly accumulates in the lung (pulmonary concentrations can be 6 to 10 times higher than those in the plasma), where it is retained even when blood levels start to decrease. The pulmonary effects can be explained by the participation of the polyamine transport system abundantly expressed in the membrane of alveolar cells type I, II, and Clara cells. Further downstream at the toxicodynamic level, the main molecular mechanism of PQ toxicity is based on redox cycling and intracellular oxidative stress generation. With this review we aimed to collect and describe the most pertinent and significant findings published in established scientific publications since the discovery of PQ, focusing on the most recent developments related to PQ lung toxicity and their relevance to the treatment of human poisonings. Considerable space is also dedicated to techniques for prognosis prediction, since these could allow development of rigorous clinical protocols that may produce comparable data for the evaluation of proposed therapies.

1 October 2014 in Toxicology Letters
Verified
Journal Article
Closed access
MBMaria Teresa Baltazar
Maria Teresa Baltazar
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
MBMaria de Lourdes Bastos
Maria de Lourdes Bastos
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
JDJosé Alberto Duarte
José Alberto Duarte
Félix CarvalhoFélix Carvalho
Félix Carvalho

21 September 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
Manuela OliveiraManuela Oliveira
Manuela Oliveira
WAWilson Antunes
Wilson Antunes
SMSalete Mota
Salete Mota
Áurea Madureira-CarvalhoÁurea Madureira-Carvalho
Áurea Madureira-Carvalho
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
DSDiana Dias da Silva
Diana Dias da Silva
Antimicrobial resistance (AMR), frequently considered a major global public health threat, requires a comprehensive understanding of its emergence, mechanisms, advances, and implications. AMR’s epidemiological landscape is characterized by its widespread prevalence and constantly evolving patterns, with multidrug-resistant organisms (MDROs) creating new challenges every day. The most common mechanisms underlying AMR (i.e., genetic mutations, horizontal gene transfer, and selective pressure) contribute to the emergence and dissemination of new resistant strains. Therefore, mitigation strategies (e.g., antibiotic stewardship programs—ASPs—and infection prevention and control strategies—IPCs) emphasize the importance of responsible antimicrobial use and surveillance. A One Health approach (i.e., the interconnectedness of human, animal, and environmental health) highlights the necessity for interdisciplinary collaboration and holistic strategies in combating AMR. Advancements in novel therapeutics (e.g., alternative antimicrobial agents and vaccines) offer promising avenues in addressing AMR challenges. Policy interventions at the international and national levels also promote ASPs aiming to regulate antimicrobial use. Despite all of the observed progress, AMR remains a pressing concern, demanding sustained efforts to address emerging threats and promote antimicrobial sustainability. Future research must prioritize innovative approaches and address the complex socioecological dynamics underlying AMR. This manuscript is a comprehensive resource for researchers, policymakers, and healthcare professionals seeking to navigate the complex AMR landscape and develop effective strategies for its mitigation.

1 May 2015 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
RSRenata Silva
Renata Silva
VVVânia Vilas-Boas
Vânia Vilas-Boas
HCHelena Carmo
Helena Carmo
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
Félix CarvalhoFélix Carvalho
Félix Carvalho
Fernando RemiãoFernando Remião
Fernando Remião

1 December 2006 in NeuroToxicology
Verified
Journal Article
Closed access
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
Fernando RemiãoFernando Remião
Fernando Remião
HCHelena Carmo
Helena Carmo
JDJosé Alberto Duarte
José Alberto Duarte
Amparo Sánchez NavarroAmparo Sánchez Navarro
Amparo Sánchez Navarro
Félix CarvalhoFélix Carvalho
Félix Carvalho

22 November 2016 in Drug Metabolism Reviews
Verified
Journal Article
Closed access
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
Psilocybin and psilocin are controlled substances in many countries. These are the two main hallucinogenic compounds of the “magic mushrooms” and both act as agonists or partial agonists at 5-hydroxytryptamine (5-HT)2A subtype receptors. During the last few years, psilocybin and psilocin have gained therapeutic relevance but considerable physiological variability between individuals that can influence dose-response and toxicological profile has been reported. This review aims to discuss metabolism of psilocybin and psilocin, by presenting all major and minor psychoactive metabolites. Psilocybin is primarily a pro-drug that is dephosphorylated by alkaline phosphatase to active metabolite psilocin. This last is then further metabolized, psilocin-O-glucuronide being the main urinary metabolite with clinical and forensic relevance in diagnosis.